Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples